Leilani Lotti Diaz earned her B.S. in Chemistry and Computer Science in 2017 from the Universidad del Sagrado Corazón in Santurce, Puerto Rico, and her M.S. in Organic Chemistry in 2019 from The Ohio State University, focusing on the synthesis of proteasome inhibitors for the treatment of multiple myeloma. She joined CAS in 2019 as a Structure Analyst for the Synthetics section specializing in small molecules.